The Philadelphia Eagles encountered intense scrutiny regarding their medical handling of quarterback Jalen Hurts following his blood clot diagnosis, but the NFL has determined the franchise will not face any penalties for its management of the alarming situation.

The league concluded the Eagles handled Hurts' clearance to compete in London appropriately, despite medical staff discovering a superficial blood clot prior to kickoff. The Eagles QB has since been sidelined for the remainder of the season.

Philadelphia will receive no disciplinary action for its medical choices or for not listing the quarterback with a game-day injury designation. NFL chief medical officer Allen Sills dismissed any criticism of the league's ruling. It comes after Dave Portnoy shares his Super Bowl contenders as 49ers continue flying start

Sills characterized reports questioning the Eagles' treatment of Hurts as "considerable and uninformed speculation" and stated that attacks on Philadelphia's team physicians were founded on baseless claims. He also voiced complete trust in all medical staffs throughout the league.

The NFL examined the circumstances surrounding Hurts' involvement against Jacksonville and deemed it acceptable. The report indicated the NFL maintained communication with the Eagles and their medical personnel during the situation and discovered no violations.

Hurts was designated as a full practice participant ahead of the London game, and medical staff concluded he could handle his typical workload, eliminating the requirement for a questionable or doubtful designation. The decision raised eyebrows given that Hurts participated in all 62 offensive plays during Philadelphia's 19-17 defeat to Jacksonville.

He subsequently joined the team on their flight back home, but additional testing conducted days afterward revealed a worrying development.

Medical staff from the team and the Cleveland Clinic evaluated his condition and authorized him to take the field against Jacksonville the following day. Sills facilitated access to international specialist consultations to enable the assessment ahead of Sunday's matchup.

The announcement came after a heated press conference and growing concerns regarding Hurts' return flight and reports that his season is essentially concluded.

Reporters questioned coach Nick Sirianni about the reasoning behind allowing Hurts to fly following the preliminary diagnosis. "I'm not a medical expert," he said.

Sirianni consistently deferred inquiries to the team's medical staff. The situation originated when Hurts reported discomfort in his left calf after being cleated during the Los Angeles Rams game.

He underwent treatment before an ultrasound in London on Oct. 10 detected a superficial venous thrombosis. Four days later, scans indicated the clot had shifted, and subsequent examinations uncovered deep vein thrombosis and bilateral pulmonary emboli.

Hurts remains stable on anticoagulant medication and is prohibited from playing contact football throughout his treatment. The Eagles and Hurts' representative Nicole Lynn provided reassurance regarding his future prognosis.